13.03.2020

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

Epidemiology Transversal
Lippi G et al
Clin Chim Acta

Main result

Platelet count: 7 studies out of a total of 9 found that patients with severe forms of COVID-19 have a lower platelet count than patients with moderate forms (mean difference between -3 and -54x10 ° 9 / L ).
2 studies show that patients with a non-severe form of the disease have a lower platelet numeration (mean difference between 27 and 31 x 10 ° 9 / L).
Meta-analysis suggests that the platelet count is statistically lower in patients with severe forms of COVID-19 (P <0.001), the results remain significant even with the exclusion of the study with the largest sample size (Guan et al, 1099 patients).
Thrombocytopenia: 4 studies (out of 9 total studies) report the values for thrombocytopenia. In these, platelet numerations ​​below the lower threshold were associated with severity.

Takeaways

The reduction in the number of platelets is significantly different between severe and non-severe cases.
Thrombocytopenia is associated with a five-fold increase in the risk of falling into a severe condition.

Strength of evidence Moderate

"moderate
1) 9 studies in meta-analysis (including 8 Chinese studies and 1 Singapore study).
A total of 1779 patients / sample varies between 12 and 1099 patients per study
2) 4 studies (out of 9) provide the value of trompocytopenia (total of 1427 patients)
3) 399 patients (22.4%) with severe patology"

Objectives

Determine if the platelet count can be used as a predictor for severity.
Assess whether thrombocytopenia is associated with a severe form of COVID-19

Method

A meta-analysis of 9 studies (8 Chinese and 1 from Singapore)

bibliovid.org and its content are bibliovid property.

Legal Notice